BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1280610)

  • 1. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
    Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
    Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production and characterisation of monoclonal antibodies to wheat gliadin peptides.
    Ellis HJ; Freedman AR; Ciclitira PJ
    J Immunol Methods; 1989 Jun; 120(1):17-22. PubMed ID: 2659671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
    Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
    Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Western immunoblotting of cereal proteins with monoclonal antibodies to wheat gliadin to investigate coeliac disease.
    Freedman AR; Galfre G; Gal E; Ellis HJ; Ciclitira PJ
    Int Arch Allergy Appl Immunol; 1988; 85(3):346-50. PubMed ID: 2450845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of gluten using a monoclonal antibody to a sequenced peptide of alpha-gliadin from the coeliac-activating domain I.
    Ellis HJ; Doyle AP; Wieser H; Sturgess RP; Day P; Ciclitira PJ
    J Biochem Biophys Methods; 1994 Jan; 28(1):77-82. PubMed ID: 7512105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificities of monoclonal antibodies to domain I of alpha-gliadins.
    Ellis HJ; Doyle AP; Wieser H; Sturgess RP; Ciclitira PJ
    Scand J Gastroenterol; 1993 Mar; 28(3):212-6. PubMed ID: 8446845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A-gliadin.
    Ellis HJ; Rosen-Bronson S; O'Reilly N; Ciclitira PJ
    Gut; 1998 Aug; 43(2):190-5. PubMed ID: 10189843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of cereals that react with serum antibodies in patients with coeliac disease.
    Troncone R; Auricchio S; De Vincenzi M; Donatiello A; Farris E; Silano V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):346-50. PubMed ID: 3430243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide.
    Morón B; Cebolla A; Manyani H; Alvarez-Maqueda M; Megías M; Thomas Mdel C; López MC; Sousa C
    Am J Clin Nutr; 2008 Feb; 87(2):405-14. PubMed ID: 18258632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody that recognizes a potential coeliac-toxic repetitive pentapeptide epitope in gliadins.
    Osman AA; Uhlig HH; Valdes I; Amin M; Méndez E; Mothes T
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1189-93. PubMed ID: 11711775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
    Kieffer M; Frazier PJ; Daniels NW; Coombs RR
    Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay for quantitation of cereal proteins toxic in coeliac disease.
    Friis SU
    Clin Chim Acta; 1988 Dec; 178(3):261-70. PubMed ID: 3240601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
    McLachlan A; Cullis PG; Cornell HJ
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins.
    Barro F; Iehisa JC; Giménez MJ; García-Molina MD; Ozuna CV; Comino I; Sousa C; Gil-Humanes J
    Plant Biotechnol J; 2016 Mar; 14(3):986-96. PubMed ID: 26300126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease.
    Mantzaris GJ; Karagiannis JA; Priddle JD; Jewell DP
    Gut; 1990 Jun; 31(6):668-73. PubMed ID: 1696236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The precipitating factor in coeliac disease.
    Wieser H
    Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.
    Spaenij-Dekking EH; Kooy-Winkelaar EM; Nieuwenhuizen WF; Drijfhout JW; Koning F
    Gut; 2004 Sep; 53(9):1267-73. PubMed ID: 15306583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta structure motif recognition by anti-gliadin antibodies in coeliac disease.
    Alfonso P; Soto C; Albar JP; Camafeita E; Escobar H; Suárez L; Rico M; Bruix M; Méndez E
    FEBS Lett; 1998 May; 427(1):36-40. PubMed ID: 9613595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.